Literature DB >> 6116795

Cardiovascular effects of lysophosphatidic acid and its structural analogs in rats.

A Tokumura, T Kume, K Fukuzawa, H Tsukatani.   

Abstract

Injection of lysophosphatidic acid into anesthetized rats induced immediate hypertension, the effect depending on the structure of the sn-1-acyl moiety of the molecule. A hydroxyl group at the sn-2-position was not necessary, but a wedgeshaped structure was suitable for hypertensive activity. Most lysophospholipids with a chemical group attached to the phosphate portion had only weak hypotensive effects, but the sn-2-acetylated analogs of these depressor lysophospholipids elicited a hypotension at much lower doses. The durations of the hypotensions evoked by the sn-2-acetylated choline phospholipids were longer than those produced by 1-palmitoyl-2-acetoyl-sn-glycerol-3-phosphorylmethanol, ethanol and propanol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116795

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Depot-specific regulation of autotaxin with obesity in human adipose tissue.

Authors:  Chloé Rancoule; Rodolphe Dusaulcy; Karine Tréguer; Sandra Grès; Charlotte Guigné; Didier Quilliot; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Physiol Biochem       Date:  2012-05-27       Impact factor: 4.158

2.  Lysophosphatidic acid acts on LPA1 receptor to increase H2 O2 during flow-induced dilation in human adipose arterioles.

Authors:  Dawid S Chabowski; Andrew O Kadlec; Karima Ait-Aissa; Joseph C Hockenberry; Paul J Pearson; Andreas M Beyer; David D Gutterman
Journal:  Br J Pharmacol       Date:  2018-10-11       Impact factor: 8.739

Review 3.  Therapeutic potential of autotaxin/lysophospholipase d inhibitors.

Authors:  Lorenzo Federico; Zehra Pamuklar; Susan S Smyth; Andrew J Morris
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

Review 4.  Lysophospholipid interactions with protein targets.

Authors:  Abby L Parrill
Journal:  Biochim Biophys Acta       Date:  2008-05-02

5.  Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation.

Authors:  Bart de Vries; Robert A Matthijsen; Annemarie A J H M van Bijnen; Tim G A M Wolfs; Wim A Buurman
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

6.  Biphasic action of platelet-activating factor on isolated guinea-pig ileum.

Authors:  A Tokumura; K Harada; K Fukuzawa; H Tsukatani
Journal:  Lipids       Date:  1983-11       Impact factor: 1.880

7.  Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis.

Authors:  K Jalink; T Hengeveld; S Mulder; F R Postma; M F Simon; H Chap; G A van der Marel; J H van Boom; W J van Blitterswijk; W H Moolenaar
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

8.  Structure and thermotropic properties of 1-stearoyl-2-acetyl-phosphatidylcholine bilayer membranes.

Authors:  J Shah; R I Duclos; G G Shipley
Journal:  Biophys J       Date:  1994-05       Impact factor: 4.033

9.  The heterotrimeric G protein subunits Gα(q) and Gβ(1) have lysophospholipase D activity.

Authors:  Chieko Aoyama; Hiroyuki Sugimoto; Hiromi Ando; Satoko Yamashita; Yasuhiro Horibata; Sayaka Sugimoto; Motoyasu Satou
Journal:  Biochem J       Date:  2011-12-01       Impact factor: 3.857

10.  Molecular mechanism of lysophosphatidic acid-induced hypertensive response.

Authors:  Kuniyuki Kano; Hirotaka Matsumoto; Asuka Inoue; Hiroshi Yukiura; Motomu Kanai; Jerold Chun; Satoshi Ishii; Takao Shimizu; Junken Aoki
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.